| Hans-Günter Meyer-Thompson | international
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19.
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19.
McCrae K, Glegg S, Goyer MÉ, Le Foll B, Brar R, Sutherland C, Fairbairn N.
Harm Reduct J. 2022 Jul 14;19(1):77. doi: 10.1186/s12954-022-00657-x. PMID: 35836189; PMCID: PMC9281344.